Global /Australia /Healthcare /Drug Manufacturers - General /EPN

Epsilon Healthcare Ltd.

EPN

• ASX: EPN • Delayed

0.0200AUD 0%

0.0143 USD

As of 5 June 2026, Epsilon Healthcare Ltd. has a market cap of $5.55M USD, ranking #44060 globally and #1535 in Australia. It ranks #3904 in the Healthcare sector, and #1253 in the Drug Manufacturers - General industry.

Global Rank

44060

Country Rank

1535

Sector Rank

3904

Industry Rank

1253

Key Stats

Market Cap

$5.55MUSD

7.78M AUD

Enterprise Value

$12.77MUSD

17.89M AUD

Revenue (TTM)

$6.7MUSD

9.39M AUD

EBITDA (TTM)

-$1.56MUSD

-2.18M AUD

Net Income (TTM)

-$912.38KUSD

-1.28M AUD

EBITDA Margin

-23%

Profit Margin

-14%

PS Ratio

0.8

PB Ratio

4.1

Company Profile

Country (HQ)

Australia

Sector

Healthcare

Industry

Drug Manufacturers - General

CEO

Peter Giannopoulos open_in_new

Founded

2016

Website

epsilonhealthcare.com.au open_in_new

warningChart data may be delayed

1d	1w	1m	3m	6m	YTD	1y	3y	5y
0%	0%	-4.8%	-33%	-8%	-39%	-8%	21%	-86%

News

Markets

Exchange	Ticker	Price	Quotes
Australian Securities Exchange (ASX) MIC: XASX PRIMARY	EPN Epsilon Healthcare Ltd ISIN: AU0000137598 Shares Out.: Shares Outstanding: 389.104M¹ Shares Float: 353.44M² TV: TradingView: ASX: EPN SA: Stock Analysis: ASX: EPN YF: Yahoo Finance: EPN.AX GF: Google Finance: ASX: EPN BA: Barron's: EPN MS: Morningstar: XASX: EPN	0.0200 AUD	TV: TradingView: ASX: EPN SA: Stock Analysis: ASX: EPN YF: Yahoo Finance: EPN.AX GF: Google Finance: ASX: EPN BA: Barron's: EPN MS: Morningstar: XASX: EPN
OTC Markets (OTCMKTS / OTC) MIC: OTCM	HDRPF Epsilon Healthcare Ltd ISIN: AU0000137598 Shares Out.: Shares Outstanding: 373.104M¹ Shares Float: 338.907M² TV: TradingView: OTC: HDRPF SA: Stock Analysis: OTC: HDRPF YF: Yahoo Finance: HDRPF GF: Google Finance: OTCMKTS: HDRPF BA: Barron's: HDRPF MS: Morningstar: PINX: HDRPF	0.0014 USD	TV: TradingView: OTC: HDRPF SA: Stock Analysis: OTC: HDRPF YF: Yahoo Finance: HDRPF GF: Google Finance: OTCMKTS: HDRPF BA: Barron's: HDRPF MS: Morningstar: PINX: HDRPF

¹Market cap is calculated using shares outstanding.

²Float shares are publicly tradable shares, excluding insider-held stock.

About Epsilon Healthcare Ltd.

Epsilon Healthcare Limited, together with its subsidiaries, engages in the healthcare business in Australia. The company operates in two segments, Contract Development and Manufacturing Activities; and Telehealth Medical Practice Services. It is involved in the healthcare and clinics operation; pharmaceutical contract development and manufacturing; development and manufacturing of active pharmaceutical ingredients and finished formulations; and provision of pharmacy services and patient care. The company was formerly known as THC Global Group Limited and changed its name to Epsilon Healthcare Limited in February 2021. Epsilon Healthcare Limited was incorporated in 2016 and is based in Southport, Australia.

Similar Companies

Industry: Drug Manufacturers - General (Australia)

Name	Market Cap (USD) diff.	PE	Country
Sigma Healthcare Ltd. ASX: SIG	$22.82B 31.98B AUD 411K%	52.3	Australia
PYC Therapeutics Ltd. ASX: PYC	$926.22M 1.3B AUD 17K%	-	Australia
Racura Oncology Ltd. ASX: RAC	$346.24M 485.18M AUD 6K%	-	Australia
Clinuvel Pharmaceuticals Ltd. ASX: CUV	$335.4M 469.99M AUD 6K%	14.5	Australia
Starpharma Holdings Ltd. ASX: SPL	$216.39M 303.23M AUD 4K%	-	Australia
Mayne Pharma Group Ltd. ASX: MYX	$166.4M 233.18M AUD 3K%	-	Australia

Industry: Drug Manufacturers - General (Global)

Name	Market Cap (USD) diff.	PE	Country
Eli Lilly and Co. NYSE: LLY	$761.68B 14M%	38.1	United States
Johnson & Johnson NYSE: JNJ	$547.28B 10M%	26.4	United States
AbbVie Inc. NYSE: ABBV	$360.63B 6M%	97.4	United States
Roche Holding AG SIX: RO	$324.68B 256.25B CHF 6M%	19.9	Switzerland
AstraZeneca PLC LSE: AZN	$289.43B 215.59B GBP 5M%	27.6	United Kingdom
Novartis AG SIX: NOVN	$277.35B 218.9B CHF 5M%	20.5	Switzerland

chevron_leftBack